Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection.

Adlam D, Olson TM, Combaret N, Kovacic JC, Iismaa SE, Al-Hussaini A, O'Byrne MM, Bouajila S, Georges A, Mishra K, Braund PS, d'Escamard V, Huang S, Margaritis M, Nelson CP, de Andrade M, Kadian-Dodov D, Welch CA, Mazurkiewicz S, Jeunemaitre X; DISCO Consortium, Wong CMY, Giannoulatou E, Sweeting M, Muller D, Wood A, McGrath-Cadell L, Fatkin D, Dunwoodie SL, Harvey R, Holloway C, Empana JP, Jouven X; CARDIoGRAMPlusC4D Study Group, Olin JW, Gulati R, Tweet MS, Hayes SN, Samani NJ, Graham RM, Motreff P, Bouatia-Naji N.

J Am Coll Cardiol. 2019 Jan 8;73(1):58-66. doi: 10.1016/j.jacc.2018.09.085.

PMID:
30621952
2.

Transglutaminase diseases: from biochemistry to the bedside.

Lorand L, Iismaa SE.

FASEB J. 2019 Jan;33(1):3-12. doi: 10.1096/fj.201801544R. Erratum in: FASEB J. 2019 Mar;33(3):4653.

PMID:
30593123
3.

Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.

Poole LG, Pant A, Baker KS, Kopec AK, Cline-Fedewa HM, Iismaa SE, Flick MJ, Luyendyk JP.

J Thromb Haemost. 2019 Jan;17(1):113-125. doi: 10.1111/jth.14330. Epub 2018 Dec 10.

PMID:
30415489
4.

Targeting transglutaminase 2 partially restores extracellular matrix structure but not alveolar architecture in experimental bronchopulmonary dysplasia.

Mižíková I, Pfeffer T, Nardiello C, Surate Solaligue DE, Steenbock H, Tatsukawa H, Silva DM, Vadász I, Herold S, Pease RJ, Iismaa SE, Hitomi K, Seeger W, Brinckmann J, Morty RE.

FEBS J. 2018 Aug;285(16):3056-3076. doi: 10.1111/febs.14596. Epub 2018 Jul 7.

5.

Cardiac hypertrophy limits infarct expansion after myocardial infarction in mice.

Iismaa SE, Li M, Kesteven S, Wu J, Chan AY, Holman SR, Calvert JW, Haq AU, Nicks AM, Naqvi N, Husain A, Feneley MP, Graham RM.

Sci Rep. 2018 Apr 17;8(1):6114. doi: 10.1038/s41598-018-24525-6.

6.

Comparative regenerative mechanisms across different mammalian tissues.

Iismaa SE, Kaidonis X, Nicks AM, Bogush N, Kikuchi K, Naqvi N, Harvey RP, Husain A, Graham RM.

NPJ Regen Med. 2018 Feb 23;3:6. doi: 10.1038/s41536-018-0044-5. eCollection 2018. Review.

7.
8.

Cardiomyocytes Replicate and their Numbers Increase in Young Hearts.

Naqvi N, Singh R, Iismaa SE, Li M, Calvert JW, Martin DI, Harvey RP, Graham RM, Husain A.

Cell. 2015 Nov 5;163(4):783-4. doi: 10.1016/j.cell.2015.10.038. No abstract available.

9.

Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period.

Cannon L, Yu ZY, Marciniec T, Waardenberg AJ, Iismaa SE, Nikolova-Krstevski V, Neist E, Ohanian M, Qiu MR, Rainer S, Harvey RP, Feneley MP, Graham RM, Fatkin D.

J Am Coll Cardiol. 2015 Feb 17;65(6):560-9. doi: 10.1016/j.jacc.2014.10.069.

10.

Thyroid hormone action in postnatal heart development.

Li M, Iismaa SE, Naqvi N, Nicks A, Husain A, Graham RM.

Stem Cell Res. 2014 Nov;13(3 Pt B):582-91. doi: 10.1016/j.scr.2014.07.001. Epub 2014 Jul 10. Review.

11.

RhoA/ROCK signaling and pleiotropic α1A-adrenergic receptor regulation of cardiac contractility.

Yu ZY, Tan JC, McMahon AC, Iismaa SE, Xiao XH, Kesteven SH, Reichelt ME, Mohl MC, Smith NJ, Fatkin D, Allen D, Head SI, Graham RM, Feneley MP.

PLoS One. 2014 Jun 11;9(6):e99024. doi: 10.1371/journal.pone.0099024. eCollection 2014.

12.

A proliferative burst during preadolescence establishes the final cardiomyocyte number.

Naqvi N, Li M, Calvert JW, Tejada T, Lambert JP, Wu J, Kesteven SH, Holman SR, Matsuda T, Lovelock JD, Howard WW, Iismaa SE, Chan AY, Crawford BH, Wagner MB, Martin DI, Lefer DJ, Graham RM, Husain A.

Cell. 2014 May 8;157(4):795-807. doi: 10.1016/j.cell.2014.03.035.

13.

Glucose homeostasis in mice is transglutaminase 2 independent.

Iismaa SE, Aplin M, Holman S, Yiu TW, Jackson K, Burchfield JG, Mitchell CJ, O'Reilly L, Davenport A, Cantley J, Schmitz-Peiffer C, Biden TJ, Cooney GJ, Graham RM.

PLoS One. 2013 May 22;8(5):e63346. doi: 10.1371/journal.pone.0063346. Print 2013.

14.

Molecular mechanism of transglutaminase-2 in corneal epithelial migration and adhesion.

Tong L, Png E, Aihua H, Yong SS, Yeo HL, Riau A, Mendoz E, Chaurasia SS, Lim CT, Yiu TW, Iismaa SE.

Biochim Biophys Acta. 2013 Jun;1833(6):1304-15. doi: 10.1016/j.bbamcr.2013.02.030. Epub 2013 Mar 4.

15.

Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation.

Basso M, Berlin J, Xia L, Sleiman SF, Ko B, Haskew-Layton R, Kim E, Antonyak MA, Cerione RA, Iismaa SE, Willis D, Cho S, Ratan RR.

J Neurosci. 2012 May 9;32(19):6561-9. doi: 10.1523/JNEUROSCI.3353-11.2012. Erratum in: J Neurosci. 2012 Aug 8;32(32):11157.

16.

Enhancing the anticancer effect of the histone deacetylase inhibitor by activating transglutaminase.

Ling D, Marshall GM, Liu PY, Xu N, Nelson CA, Iismaa SE, Liu T.

Eur J Cancer. 2012 Nov;48(17):3278-87. doi: 10.1016/j.ejca.2012.02.067. Epub 2012 Mar 27.

PMID:
22459762
17.

Transglutaminase 2 and its role in pulmonary fibrosis.

Olsen KC, Sapinoro RE, Kottmann RM, Kulkarni AA, Iismaa SE, Johnson GV, Thatcher TH, Phipps RP, Sime PJ.

Am J Respir Crit Care Med. 2011 Sep 15;184(6):699-707. doi: 10.1164/rccm.201101-0013OC. Epub 2011 Jun 23.

18.

Regulation of murine cardiac contractility by activation of α(1A)-adrenergic receptor-operated Ca(2+) entry.

Mohl MC, Iismaa SE, Xiao XH, Friedrich O, Wagner S, Nikolova-Krstevski V, Wu J, Yu ZY, Feneley M, Fatkin D, Allen DG, Graham RM.

Cardiovasc Res. 2011 Jul 15;91(2):310-9. doi: 10.1093/cvr/cvr081. Epub 2011 May 5.

PMID:
21546445
19.

Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.

McConoughey SJ, Basso M, Niatsetskaya ZV, Sleiman SF, Smirnova NA, Langley BC, Mahishi L, Cooper AJ, Antonyak MA, Cerione RA, Li B, Starkov A, Chaturvedi RK, Beal MF, Coppola G, Geschwind DH, Ryu H, Xia L, Iismaa SE, Pallos J, Pasternack R, Hils M, Fan J, Raymond LA, Marsh JL, Thompson LM, Ratan RR.

EMBO Mol Med. 2010 Sep;2(9):349-70. doi: 10.1002/emmm.201000084.

20.

Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation.

Tee AE, Marshall GM, Liu PY, Xu N, Haber M, Norris MD, Iismaa SE, Liu T.

J Biol Chem. 2010 Feb 5;285(6):3561-7. doi: 10.1074/jbc.M109.053041. Epub 2009 Dec 10.

21.

Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders.

Iismaa SE, Mearns BM, Lorand L, Graham RM.

Physiol Rev. 2009 Jul;89(3):991-1023. doi: 10.1152/physrev.00044.2008. Review.

22.

Mechanism of allosteric regulation of transglutaminase 2 by GTP.

Begg GE, Carrington L, Stokes PH, Matthews JM, Wouters MA, Husain A, Lorand L, Iismaa SE, Graham RM.

Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19683-8. Epub 2006 Dec 18.

23.

Cross-linking transglutaminases with G protein-coupled receptor signaling.

Iismaa SE, Begg GE, Graham RM.

Sci STKE. 2006 Sep 19;2006(353):pe34.

PMID:
16985237
24.

Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity.

Begg GE, Holman SR, Stokes PH, Matthews JM, Graham RM, Iismaa SE.

J Biol Chem. 2006 May 5;281(18):12603-9. Epub 2006 Mar 7.

25.

Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria.

Krasnikov BF, Kim SY, McConoughey SJ, Ryu H, Xu H, Stavrovskaya I, Iismaa SE, Mearns BM, Ratan RR, Blass JP, Gibson GE, Cooper AJ.

Biochemistry. 2005 May 31;44(21):7830-43.

26.

Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases.

Iismaa SE, Holman S, Wouters MA, Lorand L, Graham RM, Husain A.

Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12636-41. Epub 2003 Oct 17.

27.
28.

Targeted inactivation of Gh/tissue transglutaminase II.

Nanda N, Iismaa SE, Owens WA, Husain A, Mackay F, Graham RM.

J Biol Chem. 2001 Jun 8;276(23):20673-8. Epub 2001 Mar 26.

29.

GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket.

Iismaa SE, Wu MJ, Nanda N, Church WB, Graham RM.

J Biol Chem. 2000 Jun 16;275(24):18259-65.

30.

Organization and chromosomal mapping of mouse Gh/tissue transglutaminase gene (Tgm2).

Nanda N, Iismaa SE, Copeland NG, Gilbert DJ, Jenkins N, Graham RM, Sutrave P.

Arch Biochem Biophys. 1999 Jun 1;366(1):151-6.

PMID:
10334875
31.

Oxidation regulates the inflammatory properties of the murine S100 protein S100A8.

Harrison CA, Raftery MJ, Walsh J, Alewood P, Iismaa SE, Thliveris S, Geczy CL.

J Biol Chem. 1999 Mar 26;274(13):8561-9.

32.

Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli.

Yen T, Harrison CA, Devery JM, Leong S, Iismaa SE, Yoshimura T, Geczy CL.

Blood. 1997 Dec 15;90(12):4812-21.

PMID:
9389698
33.

The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.

Iismaa SE, Chung L, Wu MJ, Teller DC, Yee VC, Graham RM.

Biochemistry. 1997 Sep 30;36(39):11655-64.

PMID:
9305955
34.

Recombinant and cellular expression of the murine chemotactic protein, CP-10.

Iismaa SE, Hu S, Kocher M, Lackmann M, Harrison CA, Thliveris S, Geczy CL.

DNA Cell Biol. 1994 Feb;13(2):183-92.

PMID:
8179823
35.

Azotobacter vinelandii mutS: nucleotide sequence and mutant analysis.

Le O, Shen B, Iismaa SE, Burgess BK.

J Bacteriol. 1993 Dec;175(23):7707-10.

36.

Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10.

Lackmann M, Rajasekariah P, Iismaa SE, Jones G, Cornish CJ, Hu S, Simpson RJ, Moritz RL, Geczy CL.

J Immunol. 1993 Apr 1;150(7):2981-91.

PMID:
8454868
37.

Site-directed mutagenesis of Azotobacter vinelandii ferredoxin I. Changes in [4Fe-4S] cluster reduction potential and reactivity.

Iismaa SE, Vázquez AE, Jensen GM, Stephens PJ, Butt JN, Armstrong FA, Burgess BK.

J Biol Chem. 1991 Nov 15;266(32):21563-71.

38.

Molecular linkage of the nif/fix and nod gene regions in Rhizobium leguminosarum biovar trifolii.

Iismaa SE, Ealing PM, Scott KF, Watson JM.

Mol Microbiol. 1989 Dec;3(12):1753-64.

PMID:
2622339
39.
40.

Construction and characterization of an Azotobacter vinelandii strain with mutations in the genes encoding flavodoxin and ferredoxin I.

Martin AE, Burgess BK, Iismaa SE, Smartt CT, Jacobson MR, Dean DR.

J Bacteriol. 1989 Jun;171(6):3162-7.

41.

A gene upstream of the Rhizobium trifolii nifA gene encodes a ferredoxin-like protein.

Iismaa SE, Watson JM.

Nucleic Acids Res. 1987 Apr 10;15(7):3180. No abstract available.

Supplemental Content

Loading ...
Support Center